Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ZYME · NASDAQ · Pharmaceutical Preparations
$26.14−0.72 (−2.68%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Zymeworks (ZYME) · oqro.io/stocks/ZYME · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 18, 2026 · Filed Nov 18, 2026
Officer sold ~$382K of ZYME shares in the open marketSourcePlanned sale · Planned for Nov 18, 2026 · Notice filed Nov 18, 2026
Officer filed to sell about $395K of ZYME stockSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Officer sold ~$651K of ZYME shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Officer sold ~$192K of ZYME shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Officer sold ~$193K of ZYME shares in the open marketSourcePlanned sale · Planned for Nov 13, 2026 · Notice filed Nov 13, 2026
Officer filed to sell about $1.05M of ZYME stockSourceInsider trade · Traded Oct 9, 2026 · Filed Oct 9, 2026
Officer sold ~$358K of ZYME shares in the open marketSourcePlanned sale · Planned for Oct 9, 2026 · Notice filed Oct 9, 2026
Officer filed to sell about $349K of ZYME stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed an increased position in ZYME for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC disclosed an increased position in ZYME for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Rubric Capital Management LP disclosed an increased position in ZYME for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. no longer reported ZYME for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Perceptive Advisors LLC disclosed an increased position in ZYME for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Siren, L.L.C. disclosed a new position in ZYME for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Rubric Capital Management LP disclosed an increased position in ZYME for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Perceptive Advisors LLC disclosed an increased position in ZYME for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Rubric Capital Management LP disclosed an increased position in ZYME for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC disclosed a reduced position in ZYME for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Aug 6, 2025
Perceptive Advisors LLC disclosed a reduced position in ZYME for Q1 2025SourceInsider trade · Traded May 15, 2025 · Filed May 19, 2025
Director purchased ~$566K of ZYME shares in the open marketSourceInsider trade · Traded May 19, 2025 · Filed May 19, 2025
Director purchased ~$70K of ZYME shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 14, 2025
Rubric Capital Management LP disclosed an increased position in ZYME for Q1 2025SourceInsider trade · Traded Apr 16, 2025 · Filed Apr 18, 2025
Director purchased ~$826K of ZYME shares in the open marketSourceInsider trade · Traded Apr 17, 2025 · Filed Apr 18, 2025
Director purchased ~$631K of ZYME shares in the open marketSourceInsider trade · Traded Apr 4, 2025 · Filed Apr 7, 2025
Director purchased ~$2.19M of ZYME shares in the open marketSourceInsider trade · Traded Apr 3, 2025 · Filed Apr 7, 2025
Director purchased ~$1.43M of ZYME shares in the open marketSourceInsider trade · Traded Mar 25, 2025 · Filed Mar 27, 2025
Director purchased ~$690K of ZYME shares in the open marketSourceInsider trade · Traded Mar 26, 2025 · Filed Mar 27, 2025
Director purchased ~$537K of ZYME shares in the open marketSourceInsider trade · Traded Mar 20, 2025 · Filed Mar 24, 2025
Director purchased ~$950K of ZYME shares in the open marketSourceInsider trade · Traded Mar 21, 2025 · Filed Mar 24, 2025
Director purchased ~$397K of ZYME shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a reduced position in ZYME for Q4 2024SourceInsider trade · Traded Jan 16, 2025 · Filed Jan 21, 2025
Director purchased ~$1.69M of ZYME shares in the open marketSourceInsider trade · Traded Jan 17, 2025 · Filed Jan 21, 2025
Director purchased ~$274K of ZYME shares in the open marketSourceInsider trade · Traded Jan 13, 2025 · Filed Jan 15, 2025
Director purchased ~$993K of ZYME shares in the open marketSourceInsider trade · Traded Jan 14, 2025 · Filed Jan 15, 2025
Director purchased ~$739K of ZYME shares in the open marketSourceInsider trade · Traded Dec 27, 2024 · Filed Dec 27, 2024
Director purchased ~$1.47M of ZYME shares in the open marketSourceInsider trade · Traded Dec 26, 2024 · Filed Dec 27, 2024
Director purchased ~$240K of ZYME shares in the open marketSourceInsider trade · Traded Dec 24, 2024 · Filed Dec 27, 2024
Director purchased ~$169K of ZYME shares in the open marketSourceInsider trade · Traded Dec 20, 2024 · Filed Dec 26, 2024
Director purchased ~$9.92M of ZYME shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Perceptive Advisors LLC disclosed an increased position in ZYME for Q3 2024SourceInsider trade · Traded Apr 2, 2025 · Filed Apr 2, 2025
Director purchased ~$881K of ZYME shares in the open marketSourceInsider trade · Traded Apr 1, 2025 · Filed Apr 2, 2025
Director purchased ~$565K of ZYME shares in the open marketSourceInsider trade · Traded Mar 31, 2025 · Filed Apr 2, 2025
Director purchased ~$52K of ZYME shares in the open marketSourceInsider trade · Traded Mar 24, 2025 · Filed Mar 24, 2025
Director purchased ~$297K of ZYME shares in the open marketSourceInsider trade · Traded Mar 18, 2025 · Filed Mar 19, 2025
Director purchased ~$1.44M of ZYME shares in the open marketSourceInsider trade · Traded Mar 19, 2025 · Filed Mar 19, 2025
Director purchased ~$737K of ZYME shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 19, 2025
Director purchased ~$688K of ZYME shares in the open marketSourceInsider trade · Traded Mar 13, 2025 · Filed Mar 13, 2025
Director purchased ~$5.85M of ZYME shares in the open marketSourceInsider trade · Traded Mar 11, 2025 · Filed Mar 13, 2025
Director purchased ~$3.69M of ZYME shares in the open marketSourceInsider trade · Traded Mar 12, 2025 · Filed Mar 13, 2025
Director purchased ~$3.59M of ZYME shares in the open marketSourceInsider trade · Traded Jan 15, 2025 · Filed Jan 15, 2025
Director purchased ~$547K of ZYME shares in the open marketSourceInsider trade · Traded Jan 10, 2025 · Filed Jan 10, 2025
Director purchased ~$2.68M of ZYME shares in the open marketSourceInsider trade · Traded Jan 8, 2025 · Filed Jan 10, 2025
Director purchased ~$296K of ZYME shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 7, 2025
CEO sold ~$499K of ZYME shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 7, 2025
CEO sold ~$356K of ZYME shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 7, 2025
Officer sold ~$166K of ZYME shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 7, 2025
Officer sold ~$170K of ZYME shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 7, 2025
Officer sold ~$146K of ZYME shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 2, 2025
Director purchased ~$2.33M of ZYME shares in the open marketSourceInsider trade · Traded Dec 31, 2024 · Filed Jan 2, 2025
Director purchased ~$2.13M of ZYME shares in the open marketSourceInsider trade · Traded Dec 30, 2024 · Filed Jan 2, 2025
Director purchased ~$853K of ZYME shares in the open marketSourceInsider trade · Traded Dec 19, 2024 · Filed Dec 26, 2024
Director purchased ~$4.04M of ZYME shares in the open marketSourceInsider trade · Traded Dec 23, 2024 · Filed Dec 26, 2024
Director purchased ~$3.58M of ZYME shares in the open marketSource